Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (7) , 1960-1965
- https://doi.org/10.1016/j.bmcl.2009.02.047
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase ActivityJournal of Biological Chemistry, 2008
- Type II transmembrane serine proteases in development and diseaseThe International Journal of Biochemistry & Cell Biology, 2008
- Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesisFrontiers in Bioscience-Landmark, 2007
- Matriptase and its putative role in cancerCellular and Molecular Life Sciences, 2006
- Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental developmentOncogene, 2006
- Deletion ofcagAgene ofHelicobacter pyloriby PCR productsWorld Journal of Gastroenterology, 2005
- Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1The Journal of cell biology, 2003
- Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasisOncogene, 2002
- Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine ProteaseJournal of Biological Chemistry, 2000
- Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human MilkJournal of Biological Chemistry, 1999